Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|June 17, 2018
Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA StudyAlberto Cauli, Dafna D Gladman, Alessandro Mathieu, et al.
Joint Bone Spine|May 23, 2017
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisMarco Sebastiani, Fabiola Atzeni, Laura Milazzo, et al.
The Journal of Rheumatology|February 18, 2011
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT studyAlberto Cauli, Dafna D Gladman, Alessandro Mathieu, et al.
Modern Rheumatology|December 25, 2018
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritisMarco Sebastiani, Laura Milazzo, Fabiola Atzeni, et al.
Frontiers in Cardiovascular Medicine|March 16, 2019
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)Micaela Fredi, Laura Andreoli, Beatrice Bacco, et al.
Clinical Reviews in Allergy & Immunology|January 29, 2022
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological AssociationsMicaela Fredi, Ilaria Cavazzana, Angela Ceribelli, et al.
Frontiers in Pharmacology|April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment ResponseAntonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Medicine|March 11, 2020
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory OutcomesAntonio Vitale, Giulio Cavalli, Piero Ruscitti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Pageof 10